This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Japan Clears First iPSC Therapies for Clinical Use
Two iPSC-derived cell therapies receive time-limited authorization following early clinical trials
03/25/2026
2 min read
